Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 3.28% | 61.09 | 0.0% | $918.14m | |
| NVAX | Novavax, Inc. | 31.62% | 104.56 | 102.0% | $825.80m | |
| AMGN | Amgen, Inc. | -1.21% | 253.15 | 1.3% | $733.54m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.17% | 640.88 | 2.5% | $687.80m | |
| GILD | Gilead Sciences, Inc. | -0.44% | 76.42 | 1.0% | $676.56m | |
| BIIB | Biogen, Inc. | -0.54% | 268.35 | 1.6% | $573.84m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.66% | 299.06 | 1.9% | $522.97m | |
| ILMN | Illumina, Inc. | -1.92% | 372.12 | 3.5% | $297.26m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.98% | 112.46 | 2.0% | $230.21m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.21% | 127.98 | 4.3% | $212.65m | |
| SGEN | Seattle Genetics, Inc. | 3.34% | 176.14 | 6.1% | $207.80m | |
| SRNE | Sorrento Therapeutics, Inc. | 3.00% | 7.38 | 1.8% | $195.17m | |
| IMMU | Immunomedics, Inc. | 1.30% | 41.16 | 11.0% | $178.10m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.25% | 163.89 | 13.9% | $167.23m | |
| INCY | Incyte Corp. | 0.80% | 108.65 | 2.5% | $166.01m |
Company Profile
Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.